The ADAA conference brings together leading clinicians and researchers to present sessions and posters on treatments and potential cures of anxiety, depression, and co-occurring disorders. ADAA's conference provides early career and student opportunities to present their work and be awarded for their efforts.

 

 

Have questions? Please email: [email protected].

Hotel information

Register today to  reserve your ADAA discounter conference hotel  rate   of $229.00++ per night, plus applicable taxes. The discounted ADAA conference room rate is available through March 20, 2023, or until the room block is full

Collaborating with ADAA at our annual conference gives your organization an opportunity to reach ADAA’s vast network of psychiatrists, social workers, psychologists, counselors, researchers, and therapists before, during and after the conference. Invest in improving mental health while growing your customer relationships.

Become an ADAA sponsor or exhibitor today!

Meet Our 2023 Conference Sponsors
Diamond Level

Rogers Behavioral Health is a leading provider of evidence-based mental health services nationwide. Rogers provides inpatient, residential, and outpatient care for adults, children, and teens with depression and mood disorders, eating disorders, addiction, OCD and anxiety disorders, PTSD, and mental health disorders in kids with autism. Learn more at rogersbh.org.

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain.  We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.

Platinum Level

VistaGen Therapeutics is developing new generation medications for multiple mental health and neurology markets where current treatments are inadequate to meet the growing needs of millions of patients worldwide. Looking beyond the limitations of current treatments for anxiety, depression and suicidal ideation, VistaGen's pipeline includes three differentiated, late-stage new drug candidates, AV-101, PH10 and PH94B, each with an exceptional safety profile and fast-acting potential to treat these debilitating diseases and disorders. VistaGen is committed to improving mental health by raising awareness of the conditions that affect the daily lives of millions of patients around the world and to introducing novel treatment alternatives into inadequate treatment paradigm

Gold Level

Established in 1987, the American Foundation for Suicide Prevention is dedicated to saving lives and bringing hope to those affected by suicide. AFSP creates a culture that’s smart about mental health through education and community programs, develops suicide prevention through research and advocacy, and provides support for those affected by suicide.

McLean Hospital offers exceptional care for children and adults who are living with depression and anxiety, including OCD. A top-rated hospital by U.S. News & World Report, compassionate care at McLean is provided using evidence-based treatment methods through short-term inpatient, diagnostically-specific residential, day treatment and intensive outpatient programs.

Silver Level

Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians.

Intra-Cellular Therapies is a biopharmaceutical company founded on Dr. Paul Greengard’s Nobel Prize-winning research that uncovered how therapies affect the inner-working of cells in the body.
We leverage this intracellular approach to deliver treatments that will be transformative for people living with complex psychiatric and neurologic diseases. We celebrate science, welcome curiosity, expect collaboration and demand integrity and respect in all we do, create and deliver.
 

Mountain Valley Treatment Center provides clinically intensive residential treatment to teenagers and emerging adults struggling with severe Anxiety, Obsessive Compulsive, and related disorders. Mountain Valley is committed to providing empirically supported treatment with a specific focus on Exposure based Cognitive Behavioral Therapy.

NeuroStar delivers our advanced and unique form of TMS (transcranial magnetic stimulation), a non-invasive therapy that uses targeted magnetic pulses to stimulate areas of the brain that are underactive in people suffering from depression.

Skyland Trail is a nationally recognized nonprofit mental health treatment organization located in Atlanta offering evidence-based primary psychiatric residential treatment and day treatment programs for adults and adolescents.

Bronze Level

CBTeam is devoted to the treatment of OCD and Anxiety Disorders. Our primary treatment consists of Exposure and Response Prevention, more generally referred to as ERP or Exposure Therapy.

This is a treatment that builds confidence and reduces stress and anxiety by teaching someone how to have an effective relationship with anxiety.
 

#ffffff
Boost Search Results
On